Home
>
National Drug Code (NDC)
>
Loxapine Succinate
Loxapine Succinate - 49349-212-02 - (Loxapine Succinate)
Drug Information of Loxapine Succinate
| Product NDC: | 49349-212 |
| Proprietary Name: | Loxapine Succinate |
| Non Proprietary Name: | Loxapine Succinate |
| Active Ingredient(s): | 50 mg/1 & nbsp; Loxapine Succinate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Loxapine Succinate
| Product NDC: | 49349-212 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA072062 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110426 |
Package Information of Loxapine Succinate
| Package NDC: | 49349-212-02 |
| Package Description: | 30 CAPSULE in 1 BLISTER PACK (49349-212-02) |
NDC Information of Loxapine Succinate
| NDC Code | 49349-212-02 |
| Proprietary Name | Loxapine Succinate |
| Package Description | 30 CAPSULE in 1 BLISTER PACK (49349-212-02) |
| Product NDC | 49349-212 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Loxapine Succinate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110426 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | LOXAPINE SUCCINATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
